We are live on ! Find out more
LXRX icon

Lexicon Pharmaceuticals
LXRX

107 hedge funds and large institutions have $710M invested in Lexicon Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 29 increasing their positions, 29 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

90% more call options, than puts

Call options by funds: $2.58M | Put options by funds: $1.35M

70% more capital invested

Capital invested by funds: $417M → $710M (+$293M)

12% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 26

1% more funds holding

Funds holding: 106 → 107 (+1)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 29

2.25% less ownership

Funds ownership: 86.24% → 83.99% (-2.2%)

Holders
107
Holders Change
+1
Holders Change %
+0.94%
% of All Funds
1.88%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
29
Increased
29
Reduced
29
Closed
26
Calls
$2.58M
Puts
$1.35M
Net Calls
+$1.22M
Net Calls Change
+$437K

Top Buyers

1
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$8.4M
2
BlackRock
BlackRock
New York
+$6.72M
3
Nomura Holdings
Nomura Holdings
Japan
+$6.36M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$5.57M
5
Two Sigma Investments
Two Sigma Investments
New York
+$3.26M

Top Sellers

1
BI
BVF Inc
California
-$17.8M
2
Morgan Stanley
Morgan Stanley
New York
-$9.52M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$8.53M
4
Millennium Management
Millennium Management
New York
-$5.16M
5
Renaissance Technologies
Renaissance Technologies
New York
-$4.73M
Name Holding Trade Value Shares
Change 		Change in
Stake
AQR Capital Management
26
AQR Capital Management
Connecticut
$1.4M +$816K +117,784 +97%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$1.18M +$95.7K +13,821 +7%
Millennium Management
28
Millennium Management
New York
$1.08M -$5.16M -744,486 -80%
Bank of America
29
Bank of America
North Carolina
$1.07M +$712K +102,787 +128%
Principal Financial Group
30
Principal Financial Group
Iowa
$1.07M +$91.6K +13,226 +8%
Skandinaviska Enskilda Banken (SEB)
31
Skandinaviska Enskilda Banken (SEB)
Sweden
$1.05M – – –
PAM
32
Panagora Asset Management
Massachusetts
$1.01M +$54.2K +7,822 +5%
WG
33
Winton Group
United Kingdom
$961K -$202K -29,221 -15%
Massachusetts Financial Services
34
Massachusetts Financial Services
Massachusetts
$883K +$1.04M +150,363 New
Citadel Advisors
35
Citadel Advisors
Florida
$778K +$917K +132,492 New
SO
36
STRS Ohio
Ohio
$697K -$596K -86,100 -42%
CCIA
37
Campbell & Co Investment Adviser
Maryland
$605K +$714K +103,100 New
T. Rowe Price Associates
38
T. Rowe Price Associates
Maryland
$604K -$534K -77,144 -43%
Natixis Advisors
39
Natixis Advisors
Massachusetts
$556K -$42.5K -6,134 -6%
PPA
40
Parametric Portfolio Associates
Washington
$544K -$29.1K -4,207 -4%
Deutsche Bank
41
Deutsche Bank
Germany
$517K -$451K -65,178 -43%
Squarepoint
42
Squarepoint
New York
$514K +$498K +71,858 +459%
ECM
43
ExodusPoint Capital Management
New York
$503K +$593K +85,615 New
California Public Employees Retirement System
44
California Public Employees Retirement System
California
$497K – – –
Vontobel Holding
45
Vontobel Holding
Switzerland
$470K – – –
Stifel Financial
46
Stifel Financial
Missouri
$457K +$53.2K +7,689 +11%
California State Teachers Retirement System (CalSTRS)
47
California State Teachers Retirement System (CalSTRS)
California
$440K +$71.8K +10,371 +16%
SIC
48
Salem Investment Counselors
North Carolina
$429K – – –
OQS
49
Occudo Quantitative Strategies
Florida
$389K +$459K +66,299 New
Goldman Sachs
50
Goldman Sachs
New York
$382K -$57.5K -8,297 -11%
1
2
3 4 5

LXRX Hedge Fund Activity: Q1 2021 in Review

107 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Lexicon Pharmaceuticals (LXRX) for Q1 2021, worth a combined $710M — up 70% from $417M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new LXRX positions and 26 closed out — a net gain of 3 holders — while 29 added to existing stakes and 29 trimmed.

The largest buyer was D.E. Shaw & Co, adding an estimated $8.4M. The largest seller was BVF Inc, cutting an estimated $17.8M.

  • 107 institutional investors held Lexicon Pharmaceuticals (LXRX) as of Q1 2021, up from 106 in Q4 2020.
  • Funds reported $710M of Lexicon Pharmaceuticals stock for Q1 2021, up 70% quarter-over-quarter.
  • 29 funds opened new Lexicon Pharmaceuticals positions in Q1 2021 and 26 closed out, a net change of +3 holders.
  • The largest Lexicon Pharmaceuticals buyer in Q1 2021 was D.E. Shaw & Co, an estimated $8.4M added.
  • The largest Lexicon Pharmaceuticals seller in Q1 2021 was BVF Inc, an estimated $17.8M sold.

Based on aggregated 13F filings for Q1 2021.